Priser
Platform
Blog
Om os
Download
STRATEC
STRATEC
Deutsche Börse Xetra
0

Om

Stratec SE is a leading medical technology company specializing in the design and manufacture of automated analyzer systems and integrated solutions for the in-vitro diagnostics, clinical diagnostics, and life sciences sectors. Its primary function is to enable laboratories and biotech firms to efficiently conduct diagnostic testing by providing advanced automation, instrument platforms, and complex consumables tailored to specific customer requirements. Through its engineering expertise, Stratec SE helps streamline laboratory workflows, reduce manual intervention, and increase testing throughput, contributing to greater reliability and reproducibility in diagnostic processes. The company's solutions serve a critical role in healthcare by enhancing the capacity and accuracy of diagnostic laboratories worldwide. Founded in 1979 and headquartered in Birkenfeld, Germany, Stratec SE has developed a global presence and built longstanding partnerships with leading diagnostics and biotechnology companies. Its shares are components of indices such as the SDAX and CDAX, underscoring its significance within the European healthcare and medical technology landscape.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I STRATEC MED ENDAVU: Køb STRATEC ($SBS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i STRATEC, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerSBS
Land
Tyskland
Antal medarbejdere1.416
Hjemmesidestratec.com
SektorSundhed
IndustriMedicinsk udstyr

Udbytter

0,84EUR
'20
0,9EUR
'21
0,95EUR
'22
0,97EUR
'23
0,55EUR
'24
0,6EUR
'25
Ex-udbytte-dato30. jun. 2025
Udbytteafkast2,27%

Analytikerskøn

Baseret på 6 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%67%33%0%0%